This list is an analysis based on recent market events. It's not an investment recommendation.
About
Vidac Pharma Holding Plc, an investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases. The company is developing VDA-1102 ointment, an anti-neoplastic agent that is in Phase 2 clinical trials for triggering apoptosis in cancer cells with minimal effects on surrounding normal cells. It is also developing VDA-1102 IV, an anti-neoplastic agent; and VDA-1275, a potent small molecule new chemical entity that are in preclinical stage for use in the treatment of solid tumors. The company was incorporated in 2021 and is based in London, the United Kingdom.
The current price of T9G.XETRA is €0.43 EUR — it has increased by +8.14% in the past 24 hours. Watch Vidac Pharma stock price performance more closely on the chart.
What is Vidac Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XETRA Stock Exchange exchange Vidac Pharma stocks are traded under the ticker T9G.XETRA.
What is Vidac Pharma revenue for the last year?▼
Vidac Pharma revenue for the last year amounts to 0 EUR.
What is Vidac Pharma net income for the last year?▼
T9G.XETRA net income for the last year is -1.02M EUR.
In which sector is Vidac Pharma located?▼
Vidac Pharma operates in the Other sector.
When did Vidac Pharma complete a stock split?▼
Vidac Pharma has not had any recent stock splits.
Where is Vidac Pharma headquartered?▼
Vidac Pharma is headquartered in London, United Kingdom.